Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Paul

Showing results (631-640 of 1,550) with videos related to

Pageof 155
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2013
Vemurafenib significantly decreases glomerular filtration rateC Uthurriague, S Thellier, D Ribes, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1986
Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosaA M Philippon, G C Paul, A P Thabaut, et al.
Journal of Fluorescence|March 17, 2017
Coumarin Based Fluorescent Probe for Colorimetric Detection of Fe<sup>3+</sup> and Fluorescence Turn On-Off Response of Zn<sup>2+</sup> and Cu<sup>2</sup>Nayan Roy, Abhijit Dutta, Paritosh Mondal, et al.
The British Journal of Dermatology|March 21, 2002
Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trialB Farkas, C Paul, A Dobozy, et al.
Transplantation|November 1, 1983
Definition, genetics, and possible significance of a newly defined endothelial antigen in the ratL C Paul, G J Busch, J M Paradysz, et al.
American Journal of Physiology. Cell Physiology|December 21, 2000
MAP kinase upregulation after hematopoietic differentiation: role of chemotaxisJ A Lehman, C C Paul, M A Baumann, et al.
Der Unfallchirurg|August 1, 1996
[The pelvic digital image data bank. Experiences after 18 months in clinical practice]T Pohlemann, C Paul, A Gänsslen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2019
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 studyM G Lebwohl, K B Gordon, G Gallo, et al.
Archives of Dermatology|February 5, 1998
Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteersC Paul, S Giachetti, L Pinquier, et al.
The Journal of Communicable Diseases|December 1, 1982
Prevalence of intestinal parasitic infection in selected rural population of Arunachal PradeshR C Paul, N C Das, V M John, et al.
Pageof 155

Showing results (631-640 of 1,550) with videos related to

Sort By:
Pageof 155
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2013
Vemurafenib significantly decreases glomerular filtration rateC Uthurriague, S Thellier, D Ribes, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1986
Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosaA M Philippon, G C Paul, A P Thabaut, et al.
Journal of Fluorescence|March 17, 2017
Coumarin Based Fluorescent Probe for Colorimetric Detection of Fe<sup>3+</sup> and Fluorescence Turn On-Off Response of Zn<sup>2+</sup> and Cu<sup>2</sup>Nayan Roy, Abhijit Dutta, Paritosh Mondal, et al.
The British Journal of Dermatology|March 21, 2002
Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trialB Farkas, C Paul, A Dobozy, et al.
Transplantation|November 1, 1983
Definition, genetics, and possible significance of a newly defined endothelial antigen in the ratL C Paul, G J Busch, J M Paradysz, et al.
American Journal of Physiology. Cell Physiology|December 21, 2000
MAP kinase upregulation after hematopoietic differentiation: role of chemotaxisJ A Lehman, C C Paul, M A Baumann, et al.
Der Unfallchirurg|August 1, 1996
[The pelvic digital image data bank. Experiences after 18 months in clinical practice]T Pohlemann, C Paul, A Gänsslen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2019
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 studyM G Lebwohl, K B Gordon, G Gallo, et al.
Archives of Dermatology|February 5, 1998
Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteersC Paul, S Giachetti, L Pinquier, et al.
The Journal of Communicable Diseases|December 1, 1982
Prevalence of intestinal parasitic infection in selected rural population of Arunachal PradeshR C Paul, N C Das, V M John, et al.
Pageof 155